Intraepidermal nerve fiber density and nerve conduction study parameters correlate with clinical staging of diabetic polyneuropathy

Diabetes Research and Clinical Practice

Volumn 99, Issue 1, 2013, Pages 24-29

  Arimura, Aiko ^a,b   Deguchi, Takahisa ^a,b   Sugimoto, Kazuhiro ^c   Uto, Tadashi ^a   Nakamura, Tomonori ^a   Arimura, Yumiko ^a   Arimura, Kimiyoshi ^d   Yagihashi, Soroku ^e   Nishio, Yoshihiko ^b   Takashima, Hiroshi ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b KAGOSHIMA UNIVERSITY HOSPITAL   (Japan)

^c OHTA NISHINOUCHI HOSPITAL   (Japan)

^d Ohkatsu Neurology and Rehabilitation Hospital   (Japan)

^e HIROSAKI UNIVERSITY   (Japan)

Author keywords

Clinical staging of diabetic polyneuropathy; Intraepidermal nerve fiber densities; Nerve conduction studies

Indexed keywords

INSULIN;

ACTION POTENTIAL; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE CLASSIFICATION; DISEASE SEVERITY; ELECTROCARDIOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; INTRAEPIDERMAL NERVE FIBER DENSITY; LATENT PERIOD; MALE; MUSCLE ACTION POTENTIAL; NERVE CONDUCTION; NERVE POTENTIAL; NERVOUS SYSTEM PARAMETERS; NEUROPATHOLOGY; NEUROPHYSIOLOGY; RR INTERVAL; SKIN BIOPSY; SURAL NERVE;

ACTION POTENTIALS; ADULT; AGED; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; DOWN-REGULATION; EPIDERMIS; FEMALE; HUMANS; JAPAN; KINETICS; MALE; MIDDLE AGED; NERVE FIBERS; NERVE TISSUE PROTEINS; NEURAL CONDUCTION; POLYNEUROPATHIES; PRACTICE GUIDELINES AS TOPIC; SEVERITY OF ILLNESS INDEX; UBIQUITIN THIOLESTERASE;

EID: 84871003840     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2012.09.026     Document Type: Article

References (34)

1. Llewelyn J.G., Tomlinson D.R., Thomas P.K. Diabetin neuropathy. Peripheral neuropathy 2005, 1951-1991. Elsevier Saunders, Philadelphia. P.K. Thomas, P.J. Dyck (Eds.).
2. Dyck P.J., Sherman W.R., Hallcher L.M., Service F.J., O'Brien P.C., Grina L.A., et al. Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry. Ann Neurol 1980, 8:590-596.
3. Cornblath D.R., Chaudhry V., Carter K., Lee D., Seysedadr M., Miernicki M., et al. Total neuropathy score: validation and reliability study. Neurology 1999, 53:1660-1664.
4. Sumner C.J., Sheth S., Griffin J.W., Cornblath D.R., Polydefkis M. The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology 2003, 60:108-111.
5. Pittenger G.L., Ray M., Burcus N.I., McNulty P., Basta B., Vinik A.I. Intraepidermal nerve fibers are indicators of small-fiber neuropathy in both diabetic and nondiabetic patients. Diabetes Care 2004, 27:1974-1979.
6. Dyck P.J., Karnes J.L., Daube J., O'Brien P., Service F.J. Clinical and neuropathological criteria for the diagnosis and staging of diabetic polyneuropathy. Brain 1985, 108(Pt 4):861-880.
7. The DCCT Research Group Factors in development of diabetic neuropathy: baseline analysis of neuropathy in feasibility phase of Diabetes Control and Complications Trial (DCCT). Diabetes 1988, 37:476-481.
8. Dyck P.J., Davies J.L., Litchy W.J., O'Brien P.C. Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy Study cohort. Neurology 1997, 49:229-239.
9. Smith A.G., Ramachandran P., Tripp S., Singleton J.R. Epidermal nerve innervation in impaired glucose tolerance and diabetes-associated neuropathy. Neurology 2001, 57:1701-1704.
10. Dyck P.J., Kratz K.M., Karnes J.L., Litchy W.J., Klein R., Pach J.M., et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 1993, 43:817-824.
11. Dyck P.J. Detection characterization, and staging of polyneuropathy: assessed in diabetics. Muscle Nerve 1988, 11:21-32.
12. Yasuda H., Sanada M., Kitada K., Terashima T., Kim H., Sakaue Y., et al. Rationale and usefulness of newly devised abbreviated diagnostic criteria and staging for diabetic polyneuropathy. Diabetes Res Clin Pract 2007, 77(Suppl. 1):S178-S183.
13. Group D.N.S. Staging of diabetic polyneuropathy. Peripher Nerve 2005, 16:223-224.
14. The Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Diabetol Int 2010, 1:2-20.
15. Lauria G., Cornblath D.R., Johansson O., McArthur J.C., Mellgren S.I., Nolano M., et al. EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy. Eur J Neurol 2005, 12:747-758.
16. Kennedy W.R., Wendelschafer-Crabb G. The innervation of human epidermis. J Neurol Sci 1993, 115:184-190.
17. Dyck P.J., Karnes J.L., O'Brien P.C., Litchy W.J., Low P.A., Melton L.J. The Rochester Diabetic Neuropathy Study: reassessment of tests and criteria for diagnosis and staged severity. Neurology 1992, 42:1164-1170.
18. Levy D.M., Karanth S.S., Springall D.R., Polak J.M. Depletion of cutaneous nerves and neuropeptides in diabetes mellitus: an immunocytochemical study. Diabetologia 1989, 32:427-433.
19. Kennedy W.R., Wendelschafer-Crabb G. Utility of the skin biopsy method in studies of diabetic neuropathy. Electroencephalogr Clin Neurophysiol Suppl 1999, 50:553-559.
20. Polydefkis M., Hauer P., Griffin J.W., McArthur J.C. Skin biopsy as a tool to assess distal small fiber innervation in diabetic neuropathy. Diabetes Technol Ther 2001, 3:23-28.
21. Quattrini C., Tavakoli M., Jeziorska M., Kallinikos P., Tesfaye S., Finnigan J., et al. Surrogate markers of small fiber damage in human diabetic neuropathy. Diabetes 2007, 56:2148-2154.
22. Smith A.G., Russell J., Feldman E.L., Goldstein J., Peltier A., Smith S., et al. Lifestyle intervention for pre-diabetic neuropathy. Diabetes Care 2006, 29:1294-1299.
23. Polydefkis M., Hauer P., Sheth S., Sirdofsky M., Griffin J.W., McArthur J.C. The time course of epidermal nerve fiber regeneration: studies in normal controls and in people with diabetes, with and without neuropathy. Brain 2004, 127:1606-1615.
24. Gibbons C.H., Freeman R. Treatment-induced diabetic neuropathy: a reversible painful autonomic neuropathy. Ann Neurol 2010, 67:534-541.
25. The effect of intensive diabetes therapy on the development and progression of neuropathy. The Diabetes Control and Complications Trial Research Group. Ann Intern Med 1995, 122:561-568.
26. Young M.J., Breddy J.L., Veves A., Boulton A.J. The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. A prospective study. Diabetes Care 1994, 17:557-560.
27. Forrest K.Y., Maser R.E., Pambianco G., Becker D.J., Orchard T.J. Hypertension as a risk factor for diabetic neuropathy: a prospective study. Diabetes 1997, 46:665-670.
28. Adler A.I., Boyko E.J., Ahroni J.H., Stensel V., Forsberg R.C., Smith D.G. Risk factors for diabetic peripheral sensory neuropathy. Results of the Seattle Prospective Diabetic Foot Study. Diabetes Care 1997, 20:1162-1167.
29. Shun C.T., Chang Y.C., Wu H.P., Hsieh S.C., Lin W.M., Lin Y.H., et al. Skin denervation in type 2 diabetes: correlations with diabetic duration and functional impairments. Brain 2004, 127:1593-1605.
30. Sorensen L., Molyneaux L., Yue D.K. The relationship among pain, sensory loss, and small nerve fibers in diabetes. Diabetes Care 2006, 29:883-887.
31. Gandhi R.A., Marques J.L., Selvarajah D., Emery C.J., Tesfaye S. Painful diabetic neuropathy is associated with greater autonomic dysfunction than painless diabetic neuropathy. Diabetes Care 2010, 33:1585-1590.
32. Chao C.C., Tseng M.T., Lin Y.J., Yang W.S., Hsieh S.C., Lin Y.H., et al. Pathophysiology of neuropathic pain in type 2 diabetes: skin denervation and contact heat-evoked potentials. Diabetes Care 2010, 33:2654-2659.
33. Atherton D.D., Facer P., Roberts K.M., Misra V.P., Chizh B.A., Bountra C., et al. Use of the novel Contact Heat Evoked Potential Stimulator (CHEPS) for the assessment of small fibre neuropathy: correlations with skin flare responses and intra-epidermal nerve fibre counts. BMC Neurol 2007, 7:21.
34. Luo K.R., Chao C.C., Hsieh P.C., Lue J.H., Hsieh S.T. Effect of glycemic control on sudomotor denervation in type 2 diabetes. Diabetes Care 2012, 35:612-616.